Why Ovid Therapeutics is on the radar of many farmaceutical investors OVID
Ovid Therapeutics ($OVID) a farmaceutical company that focuses on medication for Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS) – two rare and difficult forms of epilepsy with children – noticed a powerful spike with the stock before the promising phase 2 results for a medication called Soticlestat. This medicine is being developed in a 50-50…